Comprehensive genomic profiling of tissue samples consistently achieves higher detection rates; for example, tissue biopsies have identified FGFR2 rearrangements in up to 9% of iCCA cases, compared to lower rates seen with plasma-based assays.109, 110. This evidence concerns the gene FGFR2 and infantile convulsions and choreoathetosis.